Thermo-Ablation With Radiofrequency Medical Technologies to Treat Thyroid Cancers

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)? Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:

⁃ 1\. Patients with:

• Nodule less than or equal to 2cm in size

• a. Specifically: Bethesda 5/6

• Their age is ≥18 years and ≤100 years

• Able to provide written consent

• Able to attend required follow-ups as per the protocol

Locations
Other Locations
Canada
University Health Network
RECRUITING
Toronto
Contact Information
Primary
Jesse Pasternak
jesse.pasternak@uhn.ca
(416) 340-4792
Backup
Emily Saso
emily.saso@uhn.ca
Time Frame
Start Date: 2023-04-20
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Intervention
Participants receive RFA intervention for thyroid nodule.
Related Therapeutic Areas
Sponsors
Leads: University Health Network, Toronto

This content was sourced from clinicaltrials.gov